Register Now
Course Information

Agenda

Friday, June 12, 2026
All times in Eastern Time

7:00 am
Registration, Breakfast & Exhibits
7:55 am
Welcome and Introductions
Amanda Vest, MBBS, MPH, Activity Director

8:00 am - 9:30 am
Session 1: HFrEF, Genetic and Inflammatory Cardiomyopathy

Moderator - Amanda Vest, MBBS, MPH

GDMT in 2026: Beyond the Guidelines and into Practice
Karlee Hoffman, DO
Towards Precision Medicine with Cardiac MRI for DCM
Deborah Kwon, MD
Genetic Testing: What Every HF Clinician Needs to Know
Michael Hill, MD, MS
Cardiac Sarcoidosis Across the EF Spectrum
Ziad Taimeh, MD
Cardio-Oncology in the Advanced HF Clinic
Arianne Clare Agdamag, MD
Discussion and Q&A
9:30 am
Break

10:00 am - 11:45 am
Session 2: HF and Metabolic Health

Moderator - Tuoyo Mene-Afejuko, MD

Reframing HF: Treating and Preventing the Syndrome, Its Causes, and Comorbid Conditions
Biykem Bozkurt, MD, PhD
Sex Differences in HFpEF Development and Management
Maria Mountis, DO
Diet and Exercise as Therapeutic Interventions for HFpEF
Salvatore Carbone, PhD
Metabolic Health as a Therapeutic Target for HFrEF
Amanda Vest, MBBS, MPH
CKM (cardio-kidney-metabolic) Care Models and Practical Implementation
TBD
Discussion and Q&A
11:45 am
Lunch

12:45 pm - 2:10 pm
Session 3: Future Horizons in HF and the Cardiomyopathies

Moderator - Amanda Vest, MBBS, MPH

HFrEF in the Device Era: Rise of the Machines
Jerry Estep, MD
The Promise of AI in HF: From Risk Prediction to Workflow Integration
Faculty TBD
Gene Therapies: The Future of HF Personalized Therapy?
Milind Desai, MD, MBA
Implications of a CD36 Genetic Variant as a Cause of Cardiomyopathy
Krishna Aragam, MD
Panel Discussion
2:10 pm
Break

2:40 pm - 4:00 pm
Breakout Session 1: Advanced Heart Failure Theater

Moderators - Tracey Matejka, PA-C and Rebecca Reay, CNP

Ventricular Assist Devices 101
Marjorie Urban, ACNP
Heart Transplantation 101
Tiffany Buda, RN, MSN
Challenging Cases in GDMT Management
TBD
Diuresis Pathways Across the Spectrum of Care
TBD
Panel Discussion
4:00 pm
Adjourn to networking reception

2:40 pm - 4:00 pm
Breakout Session 2: Top Five Trials of 2025-26

Moderator - Yaquta Kaka, MD

DIGIT-HF
Randall Starling, MD, MPH
VICTOR
Pavan Bhat, MD
SUMMIT and substudies
Sean Bhattacharya, MD
FINEARTS-HF and substudies, RE-DEFINE-HF
Pei Jun Zhao, MD
Neuregulin and Other Regenerative Pathways in HFrEF
W.H. Wilson Tang, MD, PhD
Panel Discussion
4:00 pm
Adjourn to networking reception

Back to top

Saturday, June 13, 2026
All times in Eastern Time

7:00 am
Registration, Breakfast & Exhibits
7:55 am
Announcements

8:00 am - 9:20 am
Session 1: Heart Failure Management

Moderator - Julia Simkowski, MD

Equitable Heart Failure Care in a CKM World
Khadijah Breathett, MD, MS
Ambulatory PA Monitoring: Who, When, How?
Miriam Jacob, MD
HF Population Health: From Individual Patients to Networks of Care
Tre Martyn, MD
When GDMT Isn't Enough: Recognizing Advanced HFrEF Before It’s Too Late
Paulino Alvarez, MD
Panel Discussion
9:20 am
Break

9:40 am - 11:10 am
Session 2: Shock and Advanced Therapies

Moderator - David Katzianer, MD

Cardiogenic Shock in 2026: From Guidelines to Bedside
Ran Lee, MD
Precision Temporary MCS Devices: When, How, and For Whom
Andrew Higgins, MD
ECMO Cannulation Strategy: VA, VAV, LAVA and more
Edward Soltesz, MD, MPH
LVAD Antithrombotic Therapy in 2026: Aspirin-Free and DOAC-Forward?
Anthony Zaki, MD
Heart Allocation by Continuous Distribution: Are We Nearly There Yet?
Eileen Hsich, MD
Panel Discussion

11:10 am - 12:30 pm
Session 3: Heart Failure Intersections

Moderator - Karen James, MD

Structural: Which Patients with AS and HFrEF Benefit Most from TAVR?
Samir Kapadia, MD
Congenital: HF Intersections Across the Lifespan
Joanna Ghobrial, MD
EP: Which Patients with AF Most Benefit from Ablation?
Oussama Wazni, MD
Surgery: Which Patients with HF can Undergo CABG and Valve Surgery?
Michael Tong, MD
Panel Discussion
12:30 pm
Lunch Break

1:15 pm - 4:00 pm
Cardiac Amyloid Session

Moderator - Preethi William, MD

New Insights Through Imaging and Tracers
Wael Jaber, MD
Evolutions in TTR Therapies
Andres Carmona Rubio, MD
Gene editing and TTR removal
Mazen Hanna, MD
AL Amyloid Conundrums (Case Based)
Jason Valent, MD
Panel Discussion
Educating Patients on an Amyloid Diagnosis
Amanda Mitchell, BSN, RN
Measuring Biomarkers and Quality of Life in Amyloidosis
J. Emanuel Finet, MD
Amyloidosis and the Musculoskeletal System
Mazen Hanna, MD
Amyloidosis as a Pro-thrombotic State
Faculty TBD
Arrhythmia Management within Amyloid Precision Care
Tyler Taigen, MD
Panel Discussion
4:00 pm
Adjourn

Back to top